Peptide record

TPDB46620

Antiviral standard
13 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB46620
Antiviral
Anti-infective peptides
Peptipedia
standard
No
A 13-aa standard-residue antiviral peptide sequence curated from Peptipedia, with an available 3D structural model.
Sequence
NLELYSLYSARGH
Physicochemical Analysis

Sequence-only estimates for a linear peptide with free termini, not experimentally measured molecular properties. Mass and formula exclude cyclization and disulfide formation. The optical estimates assume paired cysteines, 280 nm, 1 g/L and a 1 cm path. The N-end rule estimate is not a measured plasma half-life.

C68H103N19O21
DCQIKMFPTWV
L
1522.68
7.71
2
1
6
+0
1.74
-0.469
97.69
Mammalian: 1.4 hour Yeast: 3 min E.coli: >10 hour
2980
1.96
5
Residue Composition
number
1
A
1
R
1
N
0
D
0
C
1
E
0
Q
1
G
1
H
0
I
3
L
0
K
0
M
0
F
0
P
2
S
0
T
0
W
2
Y
0
V
Amino Acid Distribution
A: 1 R: 1 N: 1 D: 0 C: 0 E: 1 Q: 0 G: 1 H: 1 I: 0 L: 3 K: 0 M: 0 F: 0 P: 0 S: 2 T: 0 W: 0 Y: 2 V: 0
Chemical Descriptors
13 reviewed residue count
C68H103N19O21 sequence-only estimate (linear, free termini)
1522.68 sequence-only estimate (linear, free termini)
7.71 sequence-only estimate (linear, free termini)
+0 sequence-only estimate (linear, free termini)
1.74 sequence-only estimate (linear, free termini)
-0.469 sequence-only estimate (linear, free termini)
Evidence Records 1 records
Evidence 1 Activity

Source & Reference

NA